Recent outbreaks and cruise ship exposures are renewing the debate over whether current Andes virus precautions adequately address possible respiratory spread.

Most available drugs are effective for symptom control and structural protection, but they’re not perfect and new agents are being investigated to help close the treatment gap.

A possible first case of COVID recurrence after ensitrelvir: a vaccinated woman whose antigen levels fall and then rebound, with symptoms returning 1 day after treatment.

Daily cold exposure using cooling vests for 2 hours each morning over 6 weeks reduced body weight and body fat mass in adults with overweight or obesity. The intervention improved thermal comfort and ...

FDA-approved EB therapies expand options for gene replacement and wound healing, but success depends on careful wound preparation and timing, experts say.

"Our results suggest that a 10-day course of moxifloxacin 400 mg daily could be used as a first-line regimen to treat MG infections in settings where assessment of resistance-associated mutations is ...

According to a post hoc analysis of patients with juvenile idiopathic arthritis on tofacitinib, younger patients have higher height velocities than expected, and older patients have normal velocities.

In patients with rheumatoid arthritis and preserved kidney function, reduced initial doses of JAK inhibitors show 2-year treatment persistence and disease control similar to those with standard doses.

More than one third of US adults in the 2024 National Health Interview Survey report experiencing at least one sunburn.

Patients in the province will be able to seek care at pharmacies for conditions like head lice, nasal congestion, dry eye, and ringworm.

As more PAs consider retirement, some areas of the country may face shortages, resulting in worse access to healthcare.

Those are some of the questions dermatologists face when a patient on systemic therapy for psoriasis does not respond fully, when the patient reacts favorably at first but then treatment effectiveness ...